20:47 EDT Cathie Wood’s ARK Investment buys 135K shares of Beam Therapeutics (BEAM) today
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics’ BEAM-302: Promising Clinical Data and Market Potential Drive Buy Rating
- Beam Therapeutics presents additional data for BEAM-302 in AATD
- Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
- Biotech stocks slide as Marks resignation seen being negative for sector
- BMO says Peter Marks resignation ‘significant negative’ for biotech